Which has better valuation & earnings, ALVOW or BIVIW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alvotech $491.95M N/A N/A N/A N/A BioVie N/A N/A N/A N/A N/A

Is ALVOW or BIVIW more profitable?

Company Net Margins Return on Equity Return on Assets Alvotech N/A N/A N/A BioVie N/A N/A N/A

Which has higher valuation and earnings, APLMW or BIVIW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Apollomics $8.50M N/A N/A N/A N/A BioVie N/A N/A N/A N/A N/A

Is APLMW or BIVIW more profitable?

Company Net Margins Return on Equity Return on Assets Apollomics N/A N/A N/A BioVie N/A N/A N/A

Which has better earnings & valuation, BIVIW or ARAV?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio BioVie N/A N/A N/A N/A N/A Aravive N/A N/A N/A -$0.90 N/A

Is BIVIW or ARAV more profitable?

Company Net Margins Return on Equity Return on Assets BioVie N/A N/A N/A Aravive N/A N/A N/A

Which has preferable earnings and valuation, BIVIW or BIAFW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio BioVie N/A N/A N/A N/A N/A bioAffinity Technologies $5.85M N/A N/A N/A N/A

Is BIVIW or BIAFW more profitable?

Company Net Margins Return on Equity Return on Assets BioVie N/A N/A N/A bioAffinity Technologies N/A N/A N/A

Which has higher valuation & earnings, CDIOW or BIVIW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cardio Diagnostics $14.45K N/A N/A N/A N/A BioVie N/A N/A N/A N/A N/A

Is CDIOW or BIVIW more profitable?

Company Net Margins Return on Equity Return on Assets Cardio Diagnostics N/A N/A N/A BioVie N/A N/A N/A

BioVie (BIVIW) Competitors

$0.34 +0.02 (+5.31%)

As of 11:48 AM Eastern

Compare

BIVIW vs. ALVOW, APLMW, ARAV, BIAFW, and CDIOW

Should you buy BioVie stock or one of its competitors? BioVie's main competitors and comparable companies include Alvotech (ALVOW), Apollomics (APLMW), Aravive (ARAV), bioAffinity Technologies (BIAFW), and Cardio Diagnostics (CDIOW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does BioVie compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and BioVie (NASDAQ:BIVIW) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, media sentiment, analyst recommendations, profitability, risk and dividends.

In the previous week, Alvotech had 3 more articles in the media than BioVie. MarketBeat recorded 5 mentions for Alvotech and 2 mentions for BioVie. BioVie's average media sentiment score of 0.43 beat Alvotech's score of 0.36 indicating that BioVie is being referred to more favorably in the news media.

Company	Overall Sentiment
Alvotech	Neutral
BioVie	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Alvotech	N/A	N/A	N/A
BioVie	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alvotech	$491.95M	N/A	N/A	N/A	N/A
BioVie	N/A	N/A	N/A	N/A	N/A

Summary

Alvotech beats BioVie on 2 of the 3 factors compared between the two stocks.

How does BioVie compare to Apollomics?

Apollomics (NASDAQ:APLMW) and BioVie (NASDAQ:BIVIW) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, media sentiment, earnings, risk and dividends.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apollomics	$8.50M	N/A	N/A	N/A	N/A
BioVie	N/A	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Apollomics	N/A	N/A	N/A
BioVie	N/A	N/A	N/A

In the previous week, BioVie had 1 more articles in the media than Apollomics. MarketBeat recorded 2 mentions for BioVie and 1 mentions for Apollomics. Apollomics' average media sentiment score of 1.87 beat BioVie's score of 0.43 indicating that Apollomics is being referred to more favorably in the media.

Company	Overall Sentiment
Apollomics	Very Positive
BioVie	Neutral

Summary

Apollomics beats BioVie on 2 of the 3 factors compared between the two stocks.

How does BioVie compare to Aravive?

BioVie (NASDAQ:BIVIW) and Aravive (NASDAQ:ARAV) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings.

Company	Net Margins	Return on Equity	Return on Assets
BioVie	N/A	N/A	N/A
Aravive	N/A	N/A	N/A

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, BioVie had 2 more articles in the media than Aravive. MarketBeat recorded 2 mentions for BioVie and 0 mentions for Aravive. BioVie's average media sentiment score of 0.43 beat Aravive's score of 0.00 indicating that BioVie is being referred to more favorably in the media.

Company	Overall Sentiment
BioVie	Neutral
Aravive	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioVie	N/A	N/A	N/A	N/A	N/A
Aravive	N/A	N/A	N/A	-$0.90	N/A

Summary

BioVie and Aravive tied by winning 2 of the 4 factors compared between the two stocks.

How does BioVie compare to bioAffinity Technologies?

BioVie (NASDAQ:BIVIW) and bioAffinity Technologies (NASDAQ:BIAFW) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, media sentiment, dividends, valuation and earnings.

Company	Net Margins	Return on Equity	Return on Assets
BioVie	N/A	N/A	N/A
bioAffinity Technologies	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioVie	N/A	N/A	N/A	N/A	N/A
bioAffinity Technologies	$5.85M	N/A	N/A	N/A	N/A

In the previous week, bioAffinity Technologies had 1 more articles in the media than BioVie. MarketBeat recorded 3 mentions for bioAffinity Technologies and 2 mentions for BioVie. BioVie's average media sentiment score of 0.43 beat bioAffinity Technologies' score of 0.30 indicating that BioVie is being referred to more favorably in the media.

Company	Overall Sentiment
BioVie	Neutral
bioAffinity Technologies	Neutral

Summary

bioAffinity Technologies beats BioVie on 2 of the 3 factors compared between the two stocks.

How does BioVie compare to Cardio Diagnostics?

Cardio Diagnostics (NASDAQ:CDIOW) and BioVie (NASDAQ:BIVIW) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation and institutional ownership.

Company	Net Margins	Return on Equity	Return on Assets
Cardio Diagnostics	N/A	N/A	N/A
BioVie	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cardio Diagnostics	$14.45K	N/A	N/A	N/A	N/A
BioVie	N/A	N/A	N/A	N/A	N/A

In the previous week, Cardio Diagnostics and Cardio Diagnostics both had 2 articles in the media. Cardio Diagnostics' average media sentiment score of 0.44 beat BioVie's score of 0.43 indicating that Cardio Diagnostics is being referred to more favorably in the media.

Company	Overall Sentiment
Cardio Diagnostics	Neutral
BioVie	Neutral

Summary

Cardio Diagnostics beats BioVie on 2 of the 2 factors compared between the two stocks.

Get BioVie News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BIVIW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BIVIW vs. The Competition

Export

Metric	BioVie	Biotechnology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	N/A	$4.02B	$7.24B	$12.90B
Dividend Yield	N/A	3.63%	2.54%	11.02%
P/E Ratio	N/A	11.55	272.49	24.28
Price / Sales	N/A	1,307.91	606.96	79.45
Price / Cash	N/A	108.37	79.89	53.65
Price / Book	N/A	16.67	13.11	6.27
Net Income	N/A	-$22.76M	$3.46B	$347.96M
7 Day Performance	18.25%	3.68%	2.13%	1.56%
1 Month Performance	-7.67%	11.99%	8.29%	4.80%
1 Year Performance	N/A	58.96%	26.58%	17.12%

BioVie Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BIVIW BioVie	N/A	$0.34 +5.3%	N/A	N/A	$0.00	N/A	N/A	N/A	Short Interest Increase Gap Up
ALVOW Alvotech	N/A	$0.22 +9.1%	N/A	-67.5%	$0.00	$559.42M	N/A	4	Gap Up
APLMW Apollomics	N/A	$0.01 -14.0%	N/A	-28.4%	$0.00	$8.50M	N/A	59
ARAV Aravive	N/A	$0.04 flat	N/A	N/A	$0.00	N/A	N/A	20	High Trading Volume
BIAFW bioAffinity Technologies	N/A	$0.12 +11.7%	N/A	+90.0%	$0.00	$5.85M	N/A	10	Short Interest Increase Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BIVIW) was last updated on 8/27/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

BioVie (BIVIW) Competitors